MEDNAX 2016 Fourth Quarter Conference Call/Webcast Scheduled for Tuesday, February 7, 2017
MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Tuesday, February 7, 2017 at 10:00 a.m. ET, to
discuss results from operations for the quarter and the 12 months ended December 31, 2016. A detailed press release will be issued
the morning of February 7, 2017 before the securities markets open.
The investor conference call will be webcast and can be accessed at MEDNAX’s website, www.mednax.com/investors.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services.
Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient
outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated
professional corporations, MEDNAX provides services through a network of more than 3,600 physicians in all 50 states and Puerto
Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40
states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company.
Additional information is available at www.mednax.com.
Certain statements and information in this press release may be deemed to contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements
relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address
activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These
statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and
assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions,
expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release
are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new
information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to
risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly
Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the
Securities and Exchange Commission.
MEDNAX, Inc.
Charles Lynch, 954-384-0175, x 5692
Vice President, Strategy and Investor Relations
charles_lynch@mednax.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170120005038/en/